Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The 2024 list of medical technologies approved for innovation funding (NUB) released in Germany

On January 30, 2024, the Institute for the Hospital Remuneration System (InEK) published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2023.

Out of 981 submitted technologies, 288 (29%) received the positive status 1, which means that the suggested procedure or medical device met the NUB criteria. Now, the hospitals can negotiate the innovation funding for these technologies with the sickness funds.

Furthermore, 33 (3%) technologies received differentiated status, meaning that status 1 can be granted only under certain conditions.

Some examples of medical technologies that obtained status 1 are provided below. The technologies with differentiated status were not included in the list.

  1. Acoustic neurinoma operation with simultaneous cochlear implantation;
  2. Endo-exo prosthesis;
  3. Endoscopic creation of a sleeve gastroplasty (endoscopic sleeve gastroplasty);
  4. Endoscopic-intratumoral injection of phosphorus-32-labeled microparticles under ultrasound guidance in irresectable locally advanced pancreatic tumors;
  5. Endoscopic thermal ablation of the duodenal mucosa to reduce insulin resistance;
  6. Endovascular implantation of an extracorporeal centrifugal pump for circulatory support;
  7. Endovascular implantation of a tricuspid valve replacement;
  8. Endovascular mitral valve annuloplasty with annuloplasty band;
  9. Implant for direct acoustic stimulation of the cochlea (DACI);
  10. Insertion of coated (covered) stents with a bioactive surface for peripheral and other vessels;
  11. Intraaneurysmal hemodynamically effective implant for the endovascular treatment of intracranial aneurysms;
  12. Single-channel neurostimulator for sacral neuromodulation, rechargeable;
  13. Thrombectomy of pulmonary vessels using the disc retriever system;
  14. Uterine transplantation;
  15. Vertebral body growth modulation technique.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.